Valentı́n Mendoza
Universidad Nacional Autónoma de México(MX)
Publications by Year
Research Areas
TGF-β signaling in diseases, Angiogenesis and VEGF in Cancer, Congenital heart defects research, Pancreatic and Hepatic Oncology Research, Metabolism, Diabetes, and Cancer
Most-Cited Works
- Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.(2002)
- → TGF‐β signalling is mediated by two autonomously functioning TβRI:TβRII pairs(2011)119 cited
- → Three Key Residues Underlie the Differential Affinity of the TGFβ Isoforms for the TGFβ Type II Receptor(2005)101 cited
- → Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer(2004)86 cited
- → Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent(2001)84 cited
- → Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A–dependent eNOS inactivation(2008)82 cited
- → Soluble betaglycan reduces renal damage progression indb/dbmice(2006)71 cited
- → Assembly of TβRI:TβRII:TGFβ Ternary Complex in vitro with Receptor Extracellular Domains is Cooperative and Isoform-dependent(2005)69 cited
- → p32 (gC1qBP) Is a General Protein Kinase C (PKC)-binding Protein(2002)69 cited
- → A combination of a transforming growth factor-β antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis(2006)63 cited